# Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

> **NCT02656082** · PHASE2 · COMPLETED · sponsor: **University of Leeds** · enrollment: 25 (actual)

## Conditions studied

- Lupus Erythematosus, Discoid
- Lupus Erythematosus, Cutaneous
- Lupus Erythematosus, Chronic Cutaneous

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT02656082
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656082, "Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02656082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*